Elite Pharmaceuticals ELTP
OTC ELTP
$0.24 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:00 AM EDT

Elite Pharmaceuticals (ELTP) EBT Margin (2010 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted EBT Margin of 23.85% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 25.25 percentage points from -1.40% a year earlier but down 27.33 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) EBT Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBT Margin at Elite Pharmaceuticals was 46.16%, up 47.60 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 38.16%, up 38.28 percentage points from FY2025.

  • Annual EBT Margin shows a five-year change of +21.83 percentage points (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' EBT Margin was -0.12% in FY2025 (-1.00 pp), 0.88% in FY2024 (-10.79 pp), 11.67% in FY2023 (-7.87 pp) and 19.54% in FY2022 (+3.21 pp).
  • Quarterly EBT Margin has run from a low of -74.16% in fiscal Q3 2025 to a high of 65.95% in fiscal Q3 2026 over five years.
  • On a year-over-year basis, EBT Margin increased in four of the last eight quarters, with an average year-over-year change of +23.53 percentage points.
  • The strongest year-over-year quarter for EBT Margin in the past five years was fiscal Q3 2026, with a gain of 140.11 percentage points; the weakest was fiscal Q3 2025, with a drop of 73.56 percentage points.
  • According to Business Quant data, EBT Margin for the three prior fiscal quarters was 51.18% (Q4 2026), 65.95% (Q3 2026) and 43.20% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,137.36 Bn 1,105.95 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 617.62 Bn 536.15 Bn 17.26 Bn 26.66%
3 AbbVie 501.17 Bn 474.28 Bn 12.70 Bn 25.18%
4 Merck 368.13 Bn 322.51 Bn 12.21 Bn -4.11%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.23 Bn 234.92 Bn 12.86 Bn 18.19%
7 Amgen 236.68 Bn 192.08 Bn 7.24 Bn 27.53%
8 Gilead Sciences 190.97 Bn 165.17 Bn 6.22 Bn -131.41%
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn -4.34%
10 Elite Pharmaceuticals 268.12 Mn 149.80 Mn 13.51 Mn 23.85%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.85%
Mar 31, 2026 51.18%
Dec 31, 2025 65.95%
Sep 30, 2025 43.20%
Jun 30, 2025 -1.40%
Mar 31, 2025 60.08%
Dec 31, 2024 -74.16%
Sep 30, 2024 -50.42%
Jun 30, 2024 4.51%
Mar 31, 2024 11.31%
Dec 31, 2023 -0.61%
Sep 30, 2023 -19.30%
Jun 30, 2023 14.44%
Mar 31, 2023 -9.91%
Dec 31, 2022 32.53%
Sep 30, 2022 17.78%
Jun 30, 2022 3.99%
Mar 31, 2022 8.97%
Dec 31, 2021 25.44%
Sep 30, 2021 21.02%
API Access

Elite Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEY